Výsledky vyhľadávania - "Intensive Care Units / statistics & numerical data"

  1. 1

    Zdroj: Am J Respir Crit Care Med
    Scheer, C S, Giamarellos-Bourboulis, E J, Ferrer, R, Idelevich, E A, Annane, D, Artigas, A, Aslan, A T, Bottari, G, Bouma, H R, Černý, V, Curić Radivojević, R, Dakou, K, Dewitte, K, Elbahnasawy, M, Gründling, M, Gurjar, M, Hästbacka, J, Kyprianou, M, Laribi, S, Lassen, A, Lebedinskii, K, Máca, J, Malbrain, M L N G, Monti, G, Ostermann, M, Osthoff, M, Paiva, J-A, Sabbatucci, M, Śmiechowicz, J, Ştefan, M G, Vollmer, M, Vuković, N, Zaragkoulias, K, Reinhart, K, Linder, A, Filipescu, D, European Sepsis Care Study Group & Dalager-Pedersen, M 2025, 'Status of Sepsis Care in European Hospitals: Results from an International Cross-Sectional Survey', American Journal of Respiratory and Critical Care Medicine, vol. 211, no. 4, pp. 587-599. https://doi.org/10.1164/rccm.202406-1167OC

    Popis súboru: application/pdf

  2. 2
  3. 3
  4. 4
  5. 5
  6. 6
  7. 7
  8. 8

    Zdroj: Intensive Care Med
    Crescioli, E, Nielsen, F M, Bunzel, A-M, Eriksen, A S B, Siegemund, M, Poulsen, L M, Andreasen, A S, Bestle, M H, Iversen, S A, Brøchner, A C, Grøfte, T, Hildebrandt, T, Laake, J H, Kjær, M-B N, Lange, T, Perner, A, Klitgaard, T L, Schjørring, O L & Rasmussen, B S 2024, 'Long-term mortality and health-related quality of life with lower versus higher oxygenation targets in intensive care unit patients with COVID-19 and severe hypoxaemia', Intensive Care Medicine, vol. 50, no. 10, pp. 1603-1613. https://doi.org/10.1007/s00134-024-07613-2

    Popis súboru: application/pdf

  9. 9
  10. 10
  11. 11
  12. 12

    Prispievatelia: Buetti, Niccolò Tabah, Alexis Setti, Nour a ďalší

    Zdroj: Intensive Care Med
    Scientia
    Scientia. Dipòsit d'Informació Digital del Departament de Salut
    instname
    INTENSIVE CARE MEDICINE

    Predmety: Male, Bacteremia / drug therapy, IMPACT, Otros calificadores::Otros calificadores::Otros calificadores::/farmacoterapia, Original, [SDV]Life Sciences [q-bio], Critical Illness / mortality, Bacteremia, Medicine and Health Sciences, EPIDEMIOLOGY, Medicaments antibacterians - Ús terapèutic, Outcome indicator, Prospective Studies, DISEASES::Bacterial Infections and Mycoses::Infection::Cross Infection, Cross Infection, Other subheadings::Other subheadings::Other subheadings::/drug therapy, Intensive Care Units / statistics & numerical data, Middle Aged, Centre, Anti-Bacterial Agents, 3. Good health, [SDV] Life Sciences [q-bio], Europe, Intensive Care Units, Outcome and Process Assessment, Health Care, ENFERMEDADES::infecciones bacterianas y micosis::infecciones bacterianas::bacteriemia, Intensive Care Units/statistics & numerical data, Female, Cross Infection / mortality, Europe / epidemiology, Drug Monitoring, Drug Monitoring/methods, Bacterièmia - Tractament, Critical Illness, ICU MORTALITY, Hospital-acquired bloodstream infections, Bacteremia / mortality, Outcome and Process Assessment, Intensive Care Units / organization & administration, HEALTH CARE::Health Services Administration::Quality of Health Care::Outcome and Process Assessment (Health Care), Process indicator, Europe/epidemiology, Cross Infection / drug therapy, Humans, Bacteraemia, Drug Monitoring / statistics & numerical data, DISEASES::Bacterial Infections and Mycoses::Bacterial Infections::Bacteremia, Aged, Anti-Bacterial Agents / therapeutic use, ATENCIÓN DE SALUD::administración de los servicios de salud::calidad de la atención sanitaria::evaluación de resultados y procesos (atención a la salud), CARE, Bacteremia/mortality, Infeccions nosocomials, STATES CRITICAL ILLNESS, Health Care, Critical Illness/mortality, Anti-Bacterial Agents/therapeutic use, name=Critical Care and Intensive Care Medicine, CHEMICALS AND DRUGS::Chemical Actions and Uses::Pharmacologic Actions::Therapeutic Uses::Anti-Infective Agents::Anti-Bacterial Agents, ENFERMEDADES::infecciones bacterianas y micosis::infección::infección hospitalaria, Drug Monitoring / methods, Avaluació de resultats (Assistència sanitària), Cross Infection/mortality, COMPUESTOS QUÍMICOS Y DROGAS::acciones y usos químicos::acciones farmacológicas::usos terapéuticos::antiinfecciosos::antibacterianos

    Popis súboru: application/pdf; application/zip; text/xml

  13. 13
  14. 14

    Zdroj: Basic Clin Pharmacol Toxicol
    Henriksen, J N, Rosenquist, S B, Illum, D G & Andersen, C U 2025, 'Prevalence of Patients Admitted to Intensive Care After Administration of Chlordiazepoxide in the Emergency Room', Basic & Clinical Pharmacology & Toxicology, vol. 136, no. 4, e70018. https://doi.org/10.1111/bcpt.70018

  15. 15

    Zdroj: Crit Care
    Critical care, vol. 29, no. 1, pp. 15
    Limotai, C, Jirasakuldej, S, Wongwiangiunt, S, Tumnark, T, Suwanpakdee, P, Wangponpattanasiri, K, Rakchue, P, Tungkasereerak, C, Pleumpanupatand, P, Tansuhaj, P, Ekkachon, P, Kittipanprayoon, S, Kerddonfag, A, Pobsuk, T, Pattanateepapon, A, Phanthumchinda, K, Suwanwela, N C, Thaipisuttikul, I, Boonyapisit, K, Ingsathit, A, Pattanaprateep, O, Attia, J, McKay, G J, Rossetti, A O, Thakkinstian, A, Rukrung, C, Kangsananont, P, Mokkaew, J, Phayaph, N, Pukpraman, S, Ritrhathon, W, Jarungjitapinan, Y, Pinpradab, J, Khamhoi, N, Nookaew, M, Chauywang, P, Rojdmapitayakorn, P, Sribussara, P, Tinroongroj, W, Teeratantikanon, W, Chongsuvivatwong, T, Viratyaporn, W, Jantararotai, W, Panyawattanakit, K, Rujirarongrueng, N, Damthong, P, Udom, P, Siengsuwan, M, Phonprasori, P, Wanmuang, K, Unwanatham, N, Rattanasiri, S, Thadanipon, K, Noivong, P, Pitipanyakul, S, Rattanachaisit, W, Muangthong, W, Wittayawisawasakul, R, Deerassamee, S, Ruayruen, W, Homgrunjarut, S, Deerassamee, S, Ledprased, Y, Pankong, M & Rattanayuvakorn, P 2025, 'Efficacy of delivery of care with Tele-continuous EEG in critically ill patients: a multicenter randomized controlled trial (Tele-cRCT study) study', Critical Care, vol. 29, 15, pp. 1. https://doi.org/10.1186/s13054-024-05246-x

    Popis súboru: application/pdf

  16. 16
  17. 17
  18. 18
  19. 19
  20. 20